VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $119,310 | -10.6% | 4,434 | 0.0% | 0.05% | -10.7% |
Q2 2023 | $133,498 | +93255.2% | 4,434 | 0.0% | 0.06% | -13.8% |
Q1 2023 | $143 | +12.6% | 4,434 | 0.0% | 0.06% | +4.8% |
Q4 2022 | $127 | -99.9% | 4,434 | +1.6% | 0.06% | -26.2% |
Q3 2022 | $105,000 | -11.8% | 4,364 | 0.0% | 0.08% | +71.4% |
Q2 2022 | $119,000 | -28.7% | 4,364 | 0.0% | 0.05% | -23.4% |
Q1 2022 | $167,000 | -88.2% | 4,364 | -90.2% | 0.06% | -89.7% |
Q4 2021 | $1,421,000 | -40.7% | 44,357 | -45.5% | 0.62% | -43.8% |
Q3 2021 | $2,398,000 | -9.2% | 81,373 | +4.7% | 1.10% | -13.1% |
Q2 2021 | $2,640,000 | +236.3% | 77,701 | +221.6% | 1.27% | +256.7% |
Q1 2021 | $785,000 | +220.4% | 24,158 | +254.7% | 0.36% | +215.0% |
Q4 2020 | $245,000 | -15.2% | 6,810 | -7.6% | 0.11% | -30.2% |
Q3 2020 | $289,000 | -21.5% | 7,372 | -26.5% | 0.16% | -28.9% |
Q2 2020 | $368,000 | +23.5% | 10,027 | -1.5% | 0.23% | +17.5% |
Q4 2019 | $298,000 | – | 10,177 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |